METTAWA, Ill., Aug. 03, 2026 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today announced that materials for its 2026 Investor Day are now available in the Investor Relations section of Brunswick.com. The materials include a recorded Investor Day strategy presentation and the related slides with the presentation transcript. Investors and other interested parties may access the materials for additional detail on Brunswick’s strategic priorities, long-term growth opportunities and financial outlook. About Brunswick Corporation: Brunswick Corporation (NYSE: BC) is a global leader in marine recreation, delivering innovation that transforms experiences on the water and beyond. Its technology-driven solutions are informed by deep consumer insights and guided by the belief that “Next Never Rests™.” Brunswick is home...

Highlights (All comparisons are to the prior year period unless otherwise noted):Net sales of $544.6 million for the quarter, up 0.7% Diluted earnings per share (“EPS”) of $2.93, up 53%, and adjusted diluted EPS* of $3.08, up 50% Generated $152.6 million of cash from operating activities; repurchased $47 million of shares Earnings and cash from operating activities benefited from IEEPA tariff cost recovery* Updates its full-year guidance for 2026COLMAR, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM), a leading supplier in the motor vehicle aftermarket industry, today announced its financial results for the second quarter ended June 27, 2026. Kevin Olsen, Dorman’s Chairman, President, and Chief Executive Officer, stated, “Our second quarter results included record earnings...

Successfully completed the purchase of Aquarion Water Company of New Hampshire, Inc. and Abenaki Water Co., Inc. HAMPTON, N.H., Aug. 03, 2026 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) (Unitil or the Company) today announced Net Income of $4.7 million, or $0.26 in Earnings Per Share (EPS) for the second quarter of 2026, an increase of $0.7 million in Net Income, or $0.01 in EPS, compared to the second quarter of 2025. For the six months ended June 30, 2026, the Company reported Net Income of $37.9 million, or $2.11 in EPS, an increase of $6.4 million in Net Income, or $0.17 in EPS, when compared to the first six months of 2025. The Company’s Adjusted Net Income (a non-GAAP financial measure1), which excluded transaction-related costs in connection with the acquisition of Bangor Natural Gas Company (Bangor),...

Net Sales increased 10% to $442 million Agreed to Acquire Kanebridge Corp subsequent to quarter end – establishes industrial master distribution presence in U.S. Raises FY 2026 Net Sales and Adj. EBITDA outlook CINCINNATI, Aug. 03, 2026 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware and related products, reported financial results for the thirteen and twenty-six weeks ended June 27, 2026. Second Quarter 2026 Highlights (Thirteen weeks ended June 27, 2026)Net sales increased 9.8% to $442.3 million compared to $402.8 million in the prior year quarter Net income increased to $21.1 million, or $0.11 per diluted share, compared to $15.8 million, or $0.08 per diluted share, in the prior year quarter Adjusted diluted EPS1 totaled $0.17 per diluted share, unchanged...

Second quarter revenues of $195 million, EPS of $(0.25), Adjusted EBITDA of $5.4 millionStrong revenue growth across all three business segmentsRaises full-year 2026 guidance NEW ALBANY, Ohio, Aug. 03, 2026 (GLOBE NEWSWIRE) — CVG (NASDAQ: CVGI), a diversified industrial products and services company, today announced financial results for its second quarter ended June 30, 2026. Second Quarter 2026 Highlights (Results from Continuing Operations; compared with prior year, where comparisons are noted)Revenues of $195.2 million, up 13.5%, primarily driven by increased demand across all three segments. Gross margin expansion of 140 basis points versus Q2 2025 and 120 basis points sequentially versus Q1 2026 primarily from increased revenues and operational efficiency improvements. Operating income of $1.6 million, up $0.8 million,...

Third Quarter 2026 Diluted earnings per share (“EPS”) of $0.12 and Adjusted EPS of $1.67 BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) — Cabot Corporation (NYSE: CBT) today announced results for its third quarter fiscal year 2026. Third Quarter HighlightsThird Quarter Diluted EPS of $0.12 and Adjusted EPS of $1.67 Reinforcement Materials segment EBIT of $97 million and Performance Chemicals segment EBIT of $68 million Battery Materials product line expanding global conductive additive capacity to support growing demand; reaffirming expectation of approximately $40 million of EBITDA for the full fiscal year Awarded Platinum rating from EcoVadis for exceptional leadership in sustainability performance for the sixth consecutive year Announced a planned leadership transition, with Erica McLaughlin elected to succeed Sean Keohane as President...

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) reported today: Quarter Ended June 30, 2026 Financial Results NET INCOME attributable to common shareholders for the quarter ended June 30, 2026 was $16,434,000, or $0.08 per diluted share, compared to $743,819,000, or $3.70 per diluted share, for the prior year’s quarter. The decrease is primarily due to the $803,248,000 gain related to the 770 Broadway master lease with New York University (“NYU”) during the three months ended June 30, 2025. FUNDS FROM OPERATIONS (“FFO”) attributable to common shareholders plus assumed conversions (non-GAAP) for the quarter ended June 30, 2026 was $144,078,000, or $0.74 per diluted share, compared to $120,928,000, or $0.60 per diluted share, for the prior year’s quarter. Adjusting...

ONEOK achieves record NGL raw feed throughput volumes, driven by a 15% increase in the Gulf Coast/Permian region in second quarter 2026 compared with second quarter 2025.ONEOK, Inc.ONEOK mechanically completed its refined products pipeline expansion connecting Mid-Continent and Gulf Coast supply to the Greater Denver area and Denver International Airport.ONEOK, Inc.Record NGL Raw Feed Throughput Volumes ONEOK Increases 2026 Financial Guidance TULSA, Okla., Aug. 03, 2026 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) today announced higher second-quarter 2026 results and increased 2026 financial guidance. Unless otherwise noted, all results are compared with the same period in 2025. Highlights:Higher second-quarter 2026 results:13% increase in net income to $967 million, resulting in $1.53 per diluted share 7%...

Exceptional Order Intake and Increasing Market Share Drive Sequential Backlog Growth of 121% Aftermarket Revenue Growth of 13% Year over Year; Second Aftermarket Acquisition Completed Following Quarter End Operating Cash Flow of $12.1 Million and Free Cash Flow of $11.3 Million, Up 43% Year over Year CHICAGO, Aug. 03, 2026 (GLOBE NEWSWIRE) — FreightCar America, Inc. (NASDAQ: RAIL) (“FreightCar America” or the “Company”), a diversified manufacturer and supplier of railroad freight cars, railcar parts and components, today reported results for the second quarter ended June 30, 2026. Second Quarter 2026 HighlightsRevenues of $113.1 million, compared to $118.6 million in the second quarter of 2025, with railcar deliveries of 927 units compared to 939 units in the prior year period Aftermarket revenues grew 13% year over year, reflecting...

ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. “The second quarter reflected strong execution across CRISPR Therapeutics’ portfolio and platform,” said Samarth Kulkarni, Ph.D., Chairman and Chief Executive Officer of CRISPR Therapeutics. “CASGEVY’s momentum continued to build, highlighted by the FDA’s approval for children as young as 2 years old, while we expanded our in vivo pipeline with the initiation of Phase 1 clinical trials for CTX340 for refractory hypertension and CTX460 for alpha-1 antitrypsin deficiency. We enter the second half of 2026 well positioned, with a number of important milestones ahead across our pipeline.” Recent Highlights and Outlook Hemoglobinopathies...